Cisapride (CIS) is a prokinetic agent that increases gastrointestinal motility in normal individuals and improves constipation in Parkinson's disease (PD). We studied the effects of CIS on the clinical response and the peripheral pharmacokinetics of orally administered L-dopa given to patients with
Effect of L-Dopa Therapy on Urinary p-Tyramine Excretion and EEG Changes in Parkinson's Disease
β Scribed by BOULTON, ALAN A.; MARJERRISON, GORDON L.
- Book ID
- 109681734
- Publisher
- Nature Publishing Group
- Year
- 1972
- Tongue
- English
- Weight
- 355 KB
- Volume
- 236
- Category
- Article
- ISSN
- 0028-0836
- DOI
- 10.1038/236076a0
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Oxygen consumption and enzyme activity were evaluted in platelet mitochondria from 17 patients with Parkinson's disease. In comparison with ageβmatched controls, no consistent abnormality could be discerned in complex I, complex IIβIII, or complex IV oxygen consumption, or in the enzyme
Thirteen drug-free and not severely affected patients with idiopathic Parkinson's disease underwent an insulin-hypoglycaemia test, a TRH test and a levodopa test. The responses of growth hormone, prolactin, cortisol and thyrotropin were measured, and retested under stable therapy with levodopa and b